Fairvalue-Calculator Fairvalue-Calculator
EN DE

NatureCell Co (007390) Fair Value & Analysis

Healthcare · KR · Market cap 2.2T KRW

Price25,900 KRW
Fair Value6,531 KRW
Upside-74.8%
Quality95/100
Evidence: Low Range 4,899 KRW – 8,164 KRW

Fair value as of: Jun 25, 2026

Analysis

NatureCell Co (007390) currently trades at 25,900 KRW, while our model-based Fair Value estimate is 6,531 KRW — implying the stock looks roughly 74.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

NatureCell Co.,Ltd. manufactures and sells canned and health functional food products, beverages, stem cell, and cosmetics in South Korea and internationally. The company's products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and ETC products under the SAMMI and OEM brands. It also provides services for the preservation of blood cells, such as endothelial progenitor cells, mononuclear cells, and platelet rich plasma products. The company was formerly known as RNL Sammi CO., Ltd. and changed its name to NatureCell Co.,Ltd. in April 2013. NatureCell Co.,Ltd. was founded in 1960 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is NatureCell Co (007390) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 6,531 KRW versus a price of 25,900 KRW — about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 007390?
Our 21-model fair value for NatureCell Co is 6,531 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 25,900 KRW.
What is the quality score of 007390?
NatureCell Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.